scholarly journals 63 Anti-leukemic activity of chronic graft-versus-host disease following allogeneic bone marrow transplantation in adult patients with philadelphia chromosome-positive acute lymphoblastic leukemia

2003 ◽  
Vol 9 (2) ◽  
pp. 83-84
Author(s):  
S. Lee ◽  
D. Kim ◽  
Y. Kim ◽  
J. Hwang ◽  
H. Kim ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Acute Lymphoblastic Leukemia ◽  
Bone Marrow Transplantation ◽  
Graft Versus Host Disease ◽  
Marrow Transplantation ◽  
Lymphoblastic Leukemia ◽  
Allogeneic Bone Marrow Transplantation ◽  
Philadelphia Chromosome ◽  
Allogeneic Bone ◽  
Graft Versus Host

scholarly journals Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia

Blood ◽  
1987 ◽  
Vol 70 (2) ◽  
pp. 587-588 ◽  
Author(s):  
SJ Forman ◽  
MR O'Donnell ◽  
AP Nademanee ◽  
DS Snyder ◽  
PJ Bierman ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Acute Lymphoblastic Leukemia ◽  
Bone Marrow Transplantation ◽  
Marrow Transplantation ◽  
Lymphoblastic Leukemia ◽  
Allogeneic Bone Marrow Transplantation ◽  
Philadelphia Chromosome ◽  
Allogeneic Bone ◽  
Marrow Ablation ◽  
Philadelphia Chromosome Positive

We report the treatment outcome of allogeneic bone marrow transplantation in ten patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Six patients are alive and well for 6 to 30 months (median 19 months) after transplantation. Four patients died with transplant related complications. In view of the poor prognosis associated with this disease, marrow ablation followed by allogeneic or syngeneic marrow grafting may be the preferred treatment modality if a suitable marrow donor is available.

scholarly journals Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia

Blood ◽  
1987 ◽  
Vol 70 (2) ◽  
pp. 587-588 ◽  
Author(s):  
SJ Forman ◽  
MR O'Donnell ◽  
AP Nademanee ◽  
DS Snyder ◽  
PJ Bierman ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Acute Lymphoblastic Leukemia ◽  
Bone Marrow Transplantation ◽  
Marrow Transplantation ◽  
Lymphoblastic Leukemia ◽  
Allogeneic Bone Marrow Transplantation ◽  
Philadelphia Chromosome ◽  
Allogeneic Bone ◽  
Marrow Ablation ◽  
Philadelphia Chromosome Positive

Abstract We report the treatment outcome of allogeneic bone marrow transplantation in ten patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Six patients are alive and well for 6 to 30 months (median 19 months) after transplantation. Four patients died with transplant related complications. In view of the poor prognosis associated with this disease, marrow ablation followed by allogeneic or syngeneic marrow grafting may be the preferred treatment modality if a suitable marrow donor is available.

Sign in / Sign up

Export Citation Format

Share Document